Novel Molecular Signatures Selectively Predict Clinical Outcomes in Colon Cancer.

ABSTRACT: Among the 152,810 estimated new cases of adenocarcinoma of the colon (COAD) and the rectum (READ) in 2024, the rates of colorectal cancer (CRC) are increasing in young adults (age < 55 years) [...].

SUBMITTER: Lahorewala S 

PROVIDER: S-EPMC11940726 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature